The importance of biotechnology in health sciences: a review
Abstract
Biotechnology is an interdisciplinary field, in which various methodologies and tools are used that focus on the transformation of living organisms or substances derived from these organisms that can be directed to a specific problem.
On the one hand, biotechnology can help to introduce phenotypic and genotypic characteristics into crops, which allow the production of nutrient-enriched foods and can help reduce malnutrition in the susceptible population, in addition to involving biotechnological bases in the generation of forecasting and diagnostic techniques in both non-communicable diseases and diseases in which an infectious agent is involved, whether we talk about the generation of recombinant proteins, vaccines and molecular diagnostic techniques, which in short we can talk about the stability and/or recovery of the population’s health.
Another important field of biotechnology is the use of microorganisms and bioremediation of soils, water, waste, etc.
Therefore, this manuscript presents a review of the contributions of biotechnology in the health sciences, through the development of genetically modified crops nutritionally enriched tools, molecular diagnosis, vaccines, and waste management
Downloads
References
Gupta, V., Sengupta, M., Prakash, J., & Tripathy, B. C. (2016). An Introduction to Biotechnology. Basic and Applied Aspects of Biotechnology, 1–21. https://doi.org/10.1007/978-981-10-0875-7_1
World Health Organization. (2021). Malnutrition. Retrieved September 5, 2022, from https://www.who.int/news-room/fact-sheets/detail/malnutrition
Ghosh, S., Datta, K., & Datta, S. K. (2019). 7 - Rice vitamins. In J. Bao (Ed.), Rice (Fourth Edition) (pp. 195–220). AACC International Press. https://doi.org/10.1016/B978-0-12-811508-4.00007-1
Lucca, P., Hurrell, R., & Potrykus, I. (2002). Fighting Iron Deficiency Anemia with Iron-Rich Rice. Journal of the American College of Nutrition, 21(sup3), 184S-190S. https://doi.org/10.1080/07315724.2002.10719264.
Manjeru P, Van Biljon A, Labuschagne M. (2019) The development and release of maize fortified with provitamin A carotenoids in developing countries. Crit Rev Food Sci Nutr.59(8):1284-1293. doi: 10.1080/10408398.2017.1402751
Paine JA, Shipton CA, Chaggar S, Howells RM, Kennedy MJ, Vernon G, Wright SY, Hinchliffe E, Adams JL, Silverstone AL, Drake R. (2005). Improving the nutritional value of Golden Rice through increased pro-vitamin A content. Nat Biotechnol.;23(4):482-7. doi: 10.1038/nbt1082.
Timoneda J, Rodríguez-Fernández L, Zaragozá R, Marín MP, Cabezuelo MT, Torres L, Viña JR, Barber T. (2018).Vitamin A Deficiency and the Lung. Nutrients. 21;10(9):1132. doi: 10.3390/nu10091132.
Botella-Pavía, P., & Rodríguez-Concepción, M. (2006). Carotenoid biotechnology in plants for nutritionally improved foods. Physiologia Plantarum, 126(3), 369–381. https://doi.org/10.1111/j.1399-3054.2006.00632.x
Chakauya, E., Coxon, K. M., Whitney, H. M., Ashurst, J. L., Abell, C., & Smith, A. G. (2006). Pantothenate biosynthesis in higher plants: advances and challenges. Physiologia Plantarum, 126(3), 319–329. https://doi.org/10.1111/j.1399-3054.2006.00683.x
Ishikawa, T., Dowdle, J., & Smirnoff, N. (2006). Progress in manipulating ascorbic acid biosynthesis and accumulation in plants. Physiologia Plantarum, 126(3), 343–355. https://doi.org/10.1111/j.1399-3054.2006.00640.x
Zimmermann, M. B., & Boelaert, K. (2015). Iodine deficiency and thyroid disorders. The Lancet. Diabetes & Endocrinology, 3(4), 286–295. https://doi.org/10.1016/S2213-8587(14)70225-6
Organización Mundial de la Salud. (2020). Las 10 principales causas de muerte. Retrieved March 31, 2021, from https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
World Health Organization. (n.d.). Enfermedades Transmisibles - OPS/OMS | Organización Panamericana de la Salud. Retrieved September 5, 2022, from https://www.paho.org/es/temas/enfermedades-transmisibles
Daar, A. S., Thorsteinsdóttir, H., Martin, D. K., Smith, A. C., Nast, S., & Singer, P. A. (2002). Top ten biotechnologies for improving health in developing countries. Nature Genetics, 32(2), 229–232. https://doi.org/10.1038/ng1002-229
Akhtar, S., Nasir, J. A., & Hinde, A. (2020). The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: a systematic review and meta-analysis. BMC Public Health, 20(1), 587. https://doi.org/10.1186/s12889-020-8414-5
Louie, A. Y., Hüber, M. M., Ahrens, E. T., Rothbächer, U., Moats, R., Jacobs, R. E., … Meade, T. J. (2000). In vivo visualization of gene expression using magnetic resonance imaging. Nature Biotechnology, 18(3), 321–325. https://doi.org/10.1038/73780
Afzal, A. (2020). Molecular diagnostic technologies for COVID-19: Limitations and challenges. Journal of Advanced Research, 26, 149–159. https://doi.org/10.1016/j.jare.2020.08.002
Palmer, C. J., Lindo, J. F., Klaskala, W. I., Quesada, J. A., Kaminsky, R., Baum, M. K., & Ager, A. L. (1998). Evaluation of the OptiMAL test for rapid diagnosis of Plasmodium vivax and Plasmodium falciparum malaria. Journal of Clinical Microbiology, 36(1), 203–206. https://doi.org/10.1128/JCM.36.1.203-206.1998
Bumgarner, R. (2013). Overview of DNA microarrays: types, applications, and their future. Current Protocols in Molecular Biology, Chapter 22, Unit 22.1. https://doi.org/10.1002/0471142727.mb2201s101
Li, Z., Dong, P., Ren, M., Song, Y., Qian, X., Yang, Y., … Liu, F. (2016). PD-L1 Expression Is Associated with Tumor FOXP3+ Regulatory T-Cell Infiltration of Breast Cancer and Poor Prognosis of Patient. Journal of Cancer, 7(7), 784–793. https://doi.org/10.7150/jca.14549
Walsh, G. (2003). Pharmaceutical biotechnology products approved within the European Union. European Journal of Pharmaceutics and Biopharmaceutics, 55(1), 3–10. https://doi.org/10.1016/S0939-6411(02)00165-0
Dingermann, T. (2008). Recombinant therapeutic proteins: production platforms and challenges. Biotechnology Journal, 3(1), 90–97. https://doi.org/10.1002/biot.200700214
Graumann, K., & Premstaller, A. (2006). Manufacturing of recombinant therapeutic proteins in microbial systems. Biotechnology Journal, 1(2), 164–186. https://doi.org/10.1002/biot.200500051
Daud, S., Shahzad, S., Shafique, M., Bhinder, M. A., Niaz, M., Naeem, A., … Husnain, T. (2014). Optimization and Validation of PCR protocol for three Hypervariable Regions (HVI, HVII and HVIII) in Human Mitochondrial DNA. Advancements in Life Sciences, 1(3), 165–170.
Baker, B. K. (2016). Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere. PLOS Medicine, 13(3), e1001970. https://doi.org/10.1371/journal.pmed.1001970
Gessner, B. D., Kaslow, D., Louis, J., Neuzil, K., O’Brien, K. L., Picot, V., … Nelson, C. B. (2017). Estimating the full public health value of vaccination. Vaccine, 35(46), 6255–6263. https://doi.org/10.1016/j.vaccine.2017.09.048
Shaker, M., Phillips, E., Blumenthal, K. G., Abrams, E. M., Banerji, A., Oppenheimer, J., … Greenhawt, M. (2021). The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis. The Journal of Allergy and Clinical Immunology. In Practice, 9(7), 2556–2561. https://doi.org/10.1016/j.jaip.2021.04.015
Nascimento, I. P., & Leite, L. C. C. (2012). Recombinant vaccines and the development of new vaccine strategies. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas, 45(12), 1102–1111. https://doi.org/10.1590/s0100-879x2012007500142
Pollet, J., Chen, W.-H., & Strych, U. (2021). Recombinant protein vaccines, a proven approach against coronavirus pandemics. Advanced Drug Delivery Reviews, 170, 71–82. https://doi.org/10.1016/j.addr.2021.01.001
Ada, G. (2005). Overview of vaccines and vaccination. Molecular Biotechnology, 29(3), 255–272. https://doi.org/10.1385/MB:29:3:255
Zhang, L., Wang, W., & Wang, S. (2015). Effect of vaccine administration modality on immunogenicity and efficacy. Expert Review of Vaccines, 14(11), 1509–1523. https://doi.org/10.1586/14760584.2015.1081067
Dua, M., Singh, A., Sethunathan, N., & Johri, A. K. (2002). Biotechnology and bioremediation: successes and limitations. Applied Microbiology and Biotechnology, 59(2–3), 143–152. https://doi.org/10.1007/s00253-002-1024-6
Watanabe, K. (2001). Microorganisms relevant to bioremediation. Current Opinion in Biotechnology, 12(3), 237–241. https://doi.org/10.1016/S0958-1669(00)00205-6
Kapahi, M., & Sachdeva, S. (2019). Bioremediation Options for Heavy Metal Pollution. Journal of Health & Pollution, 9(24), 191203. https://doi.org/10.5696/2156-9614-9.24.191203
Kour, D., Kaur, T., Devi, R., Yadav, A., Singh, M., Joshi, D., Saxena, A. K. (2021). Beneficial microbiomes for bioremediation of diverse contaminated environments for environmental sustainability: present status and future challenges. Environmental Science and Pollution Research International, 28(20), 24917–24939. https://doi.org/10.1007/s11356-021-13252-7
Ito, A., Takachi, T., Aizawa, J., & Umita, T. (2001). Chemical and biological removal of arsenic from sewage sludge. Water Science and Technology, 44(10), 59–64. https://doi.org/10.2166/wst.2001.0581
Akash, S., Sivaprakash, B., Rajamohan, N., Pandiyan, C. M., & Vo, D.-V. N. (2022). Pesticide pollutants in the environment – A critical review on remediation techniques, mechanism and toxicological impact. Chemosphere, 301, 134754. https://doi.org/10.1016/j.chemosphere.2022.134754
Hamoda, M. F. (2006). Air pollutants emissions from waste treatment and disposal facilities. Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering, 41(1), 77–85. https://doi.org/10.1080/10934520500298895
Watson, R. E., Jacobson, C. F., Williams, A. L., Howard, W. B., & DeSesso, J. M. (2006). Trichloroethylene-contaminated drinking water and congenital heart defects: A critical analysis of the literature. Reproductive Toxicology, 21(2), 117–147. https://doi.org/10.1016/j.reprotox.2005.07.013
Head, I. M., & Swannell, R. P. (1999). Bioremediation of petroleum hydrocarbon contaminants in marine habitats. Current Opinion in Biotechnology, 10(3), 234–239. https://doi.org/10.1016/S0958-1669(99)80041-X
